Chennai Meenakshi Multispeciality Hospital Ltd vs Kovai Medical Center Hospital Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Nov 01, 2026

Key Highlights

The Latest Trading Price of Chennai Meenakshi Multispeciality Hospital Ltd is ₹ 33.15 as of 30 Oct 15:30 . The P/E Ratio of Chennai Meenakshi Multispeciality Hospital Ltd changed from 4.3 on March 2022 to 0 on March 2026 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Kovai Medical Center & Hospital Ltd changed from 15.5 on March 2021 to 22.5 on March 2026 . This represents a CAGR of 6.41% over 6 years The Market Cap of Chennai Meenakshi Multispeciality Hospital Ltd changed from ₹ 7.28 crore on March 2021 to ₹ 24.66 crore on March 2026 . This represents a CAGR of 22.55% over 6 yearsThe Market Cap of Kovai Medical Center & Hospital Ltd changed from ₹ 1206 crore on March 2021 to ₹ 5494 crore on March 2026 . This represents a CAGR of 28.75% over 6 years The revenue of Chennai Meenakshi Multispeciality Hospital Ltd for the Jun '26 is ₹ 8.7 crore as compare to the Mar '26 revenue of ₹ 10.05 crore. This represent the decline of -13.43% The revenue of Kovai Medical Center & Hospital Ltd for the Jun '26 is ₹ 438.65 crore as compare to the Mar '26 revenue of ₹ 421.67 crore. This represent the growth of 4.03% The ebitda of Chennai Meenakshi Multispeciality Hospital Ltd for the Jun '26 is ₹ 0.46 crore as compare to the Mar '26 ebitda of ₹ 0.48 crore. This represent the decline of -4.17% The ebitda of Kovai Medical Center & Hospital Ltd for the Jun '26 is ₹ 131.28 crore as compare to the Mar '26 ebitda of ₹ 119.05 crore. This represent the growth of 10.27% The net profit of Chennai Meenakshi Multispeciality Hospital Ltd changed from ₹ -0.38 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The net profit of Kovai Medical Center & Hospital Ltd changed from ₹ 45.75 crore to ₹ 69.09 crore over 9 quarters. This represents a CAGR of 20.11% The Dividend Payout of Chennai Meenakshi Multispeciality Hospital Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Kovai Medical Center & Hospital Ltd changed from 4.22 % on March 2021 to 6.71 % on March 2026 . This represents a CAGR of 8.04% over 6 years .

About Chennai Meenakshi Multispeciality Hospital Ltd

Chennai Meenakshi Multispeciality Hospital Limited, formerly known as Devaki Hospital Limited, was incorporated in 1990.
The Company name was changed from Devaki Hospital Limited to Chennai Meenakshi Multispeciality Hospital Limited in October, 2007.
It is a 100-bedded hospital located in the heart of Chennai at Mylapore.
The hospital has an infrastructure comprising of around 105 Beds including ICU Beds, Operating Theatre, a modern dialysis Unit besides a host of other facilities.
The Company has a pool of talented and experienced doctors who are further supported by a team of highly qualified and experienced and dedicated support staff and cutting edge technology. The Company operate into various departments like Cardiology Department; Casualty Department; Diagnostic Services; Intensive Care Unit; Nephrology Department and Physiotherapy Department.

About Kovai Medical Center & Hospital Ltd

Kovai Medical Center and Hospital Limited was incorporated as a Public Company in year 1985 and commenced its hospital operation in year 1990 with the flagship of Multi-Speciality Hospital at Coimbatore with a capacity of 200 Bed Hospital.
Thereafter, the Hospital set up the satellite centers at Coimbatore in the name of City Center, Sulur Hospital and Kovilpalayam Hospital and Erode in the name of Erode Speciality Hospital. Today, KMCH has grown into a 2,250 bed multi-locational, multi-disciplinary Super specialty hospital, the best and most trusted in Southern India.
The Hospital is equipped with most modern equipments like CT Scanner, Angiograpy equipment with DSA, Operating Microscope, Mammography, C-arm, Color Doppler etc.
There are over 30 Medical Departments and 11 Operation Theatres at the Hospital.

FAQs for the comparison of Chennai Meenakshi Multispeciality Hospital Ltd and Kovai Medical Center & Hospital Ltd

Which company has a larger market capitalization, Chennai Meenakshi Multispeciality Hospital Ltd or Kovai Medical Center & Hospital Ltd?

Market cap of Chennai Meenakshi Multispeciality Hospital Ltd is 24 Cr while Market cap of Kovai Medical Center & Hospital Ltd is 6,354 Cr

What are the key factors driving the stock performance of Chennai Meenakshi Multispeciality Hospital Ltd and Kovai Medical Center & Hospital Ltd?

The stock performance of Chennai Meenakshi Multispeciality Hospital Ltd and Kovai Medical Center & Hospital Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Chennai Meenakshi Multispeciality Hospital Ltd and Kovai Medical Center & Hospital Ltd?

As of November 1, 2026, the Chennai Meenakshi Multispeciality Hospital Ltd stock price is INR ₹33.15. On the other hand, Kovai Medical Center & Hospital Ltd stock price is INR ₹5808.45.

How do dividend payouts of Chennai Meenakshi Multispeciality Hospital Ltd and Kovai Medical Center & Hospital Ltd compare?

To compare the dividend payouts of Chennai Meenakshi Multispeciality Hospital Ltd and Kovai Medical Center & Hospital Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.